Search | TVST | ARVO Journals

View

Showing 1 – 8 of 8

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Recombinant Deoxyribonuclease I (DNase) Eye Drops for Ocular Graft vs Hosts Disease (oGVHD): Results of a Randomized Clinical Trial

Bayasgalan Surenkhuu; Christine Mun; Nour Atassi; Nikhil Dhall; Jessica Mun; Caitlin Berek; Christian Kim; Monazzah Akbar Sarwar; Anubhav Pradeep; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1276.

ARVO Annual Meeting Abstract June 2021

Ocular Graft vs Hosts Disease (oGVHD) After Allogenic Hematopoietic Stem Cell Transplant (allo-HSCT): A 2 Year Longitudinal, Observational Study

Nour Atassi; Bayasgalan Surenkhuu; Jessica Mun; Caitlin Berek; Anna Ahn; Nikhil Dhall; Christian Kim; Sarah Abdul-Hadi; Anubhav Pradeep; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1244.

ARVO Annual Meeting Abstract July 2019

Anti-Citrullinated Protein Antibodies (ACPA) are Present in Tear Fluid of Dry Eye Disease (DED) Patients: Diagnostic and Therapeutic Implications

Sandeep Jain; SEUNGWON AN; Jieun Kwon; Bayasgalan Surenkhuu; Illangovan Raju; Nour Atassi; Anubhav Pradeep; Christine Mun

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6786.

ARVO Annual Meeting Abstract July 2019

Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients with Dry Eye Disease: Results of a Randomized Clinical Trial

Christine Mun; Sapna Tibrewal; Anna Ahn; Azucena Lopez; Nour Atassi; Bayasgalan Surenkhuu; Morgan Buwick; Hirali Shah; Shivali Shukla; Jessica Mun; Anubhav Pradeep; Illangovan Raju; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6759.

ARVO Annual Meeting Abstract July 2019

LIGHT Protein is a Potential Biomarker for Ocular Graft-VS-Host Disease (oGVHD)

Bayasgalan Surenkhuu; Illangovan Raju; SEUNGWON AN; Jieun Kwon; Anubhav Pradeep; Nour Atassi; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6764.

ARVO Annual Meeting Abstract July 2019

Superior limbic keratoconjunctivitis: An analysis of clinical and pathophysiological features and therapeutic outcomes

Morgan Buwick; Levi Kanu; Bayasgalan Surenkhuu; Christine Mun; Nour Atassi; Shivali Shukla; Hirali Shah; Jessica Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2774.

ARVO Annual Meeting Abstract July 2019

Sub-Anticoagulant Dose Heparin Dismantles Neutrophil Extracellular Traps (NETs): Therapeutic Implementations for Dry Eye Disease (DED)

Jieun Kwon; SEUNGWON AN; Illangovan Raju; Bayasgalan Surenkhuu; Anubhav Pradeep; Christine Mun; Nour Atassi; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):309.

Clinical Trials May 2019

A Phase I/II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients With Dry Eye Disease

PDF

Christine Mun; Shilpa Gulati; Sapna Tibrewal; Yi-Fan Chen; Seungwon An; Bayasgalan Surenkhuu; Ilangovan Raju; Morgan Buwick; Anna Ahn; Ji-Eun Kwon; Nour Atassi; Anubhav Pradeep; Damiano Rondelli; Sandeep Jain
TAGS: deoxyribonucleases, dry eye syndromes, eyedrops, placebos, deoxyribonuclease i
Trans. Vis. Sci. Tech.. 2019; 8(3):10. https://doi.org/10.1167/tvst.8.3.10

Advertisement